Evogene (EVGN) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free EVGN Stock Alerts $0.66 +0.01 (+1.54%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Evogene Short Interest DataCurrent Short Volume97,800 sharesPrevious Short Volume69,700 sharesChange Vs. Previous Month+40.32%Dollar Volume Sold Short$67,755.84Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares41,220,000 sharesPercentage of Shares Shorted0.24%Today's Trading Volume69,204 sharesAverage Trading Volume43,240 sharesToday's Volume Vs. Average160% Short Selling Evogene ? Sign up to receive the latest short interest report for Evogene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEVGN Short Interest Over TimeEVGN Days to Cover Over TimeEVGN Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Evogene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202497,800 shares $67,755.84 +40.3%N/A0.6 $0.69 4/15/202469,700 shares $47,835.11 -19.4%N/A0.4 $0.69 3/31/202486,500 shares $64,875.00 +20.8%N/A0.5 $0.75 3/15/202471,600 shares $58,712.00 -47.5%N/A0.4 $0.82 2/29/2024136,300 shares $124,196.56 +25.7%N/A0.6 $0.91 2/15/2024108,400 shares $81,137.40 -11.0%N/A0.5 $0.75 Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024121,800 shares $93,177.00 -3.0%N/A0.8 $0.77 1/15/2024125,500 shares $117,719.00 -18.4%N/A0.8 $0.94 12/31/2023153,700 shares $129,108.00 -17.9%N/A1 $0.84 12/15/2023187,200 shares $131,189.76 -35.0%N/A1.3 $0.70 11/30/2023287,800 shares $187,127.56 +32.3%N/A2.3 $0.65 11/15/2023217,500 shares $143,898.00 +20.6%N/A2 $0.66 10/31/2023180,400 shares $86,429.64 -28.8%N/A1.3 $0.48 10/15/2023253,400 shares $118,616.54 -11.3%N/A1.6 $0.47 9/30/2023285,600 shares $167,504.40 +20.0%N/A1 $0.59 9/15/2023238,000 shares $159,698.00 -8.9%N/A0.7 $0.67 8/31/2023261,100 shares $194,075.63 -12.7%N/A0.7 $0.74 8/15/2023299,200 shares $238,163.20 -10.7%N/A0.8 $0.80 7/31/2023334,900 shares $354,994.00 -33.8%N/A1 $1.06 7/15/2023505,800 shares $708,120.00 -8.5%N/A1.7 $1.40 6/30/2023552,800 shares $591,496.00 +118.7%1.4%3.5 $1.07 6/15/2023252,800 shares $195,161.60 +13.0%0.6%2 $0.77 5/31/2023223,800 shares $134,324.76 -22.5%0.6%3.1 $0.60 5/15/2023288,700 shares $193,313.52 +13.4%0.7%3.9 $0.67 4/30/2023254,500 shares $149,111.55 -1.3%0.6%3.1 $0.59 4/15/2023257,900 shares $149,917.27 +2.6%0.7%2.8 $0.58 3/31/2023251,300 shares $158,319.00 +42.9%0.6%2.6 $0.63 3/15/2023175,900 shares $115,918.10 +11.2%0.4%1.6 $0.66 2/28/2023158,200 shares $120,232.00 -31.2%0.4%1.5 $0.76 2/15/2023230,000 shares $195,500.00 -7.9%0.6%2.1 $0.85 1/31/2023249,600 shares $199,655.04 +45.0%0.6%2.4 $0.80 1/15/2023172,200 shares $129,150.00 -0.9%0.4%1.9 $0.75 12/30/2022173,800 shares $121,660.00 -35.2%0.4%2 $0.70 12/15/2022268,100 shares $189,653.94 +42.6%0.7%2.9 $0.71 11/30/2022188,000 shares $117,970.00 -5.8%0.5%2.5 $0.63 11/15/2022199,600 shares $143,712.00 -19.4%0.5%2.5 $0.72 10/31/2022247,500 shares $180,675.00 +23.9%0.6%2.6 $0.73 10/15/2022199,700 shares $141,767.03 +3.2%0.5%1.9 $0.71 9/30/2022193,500 shares $160,605.00 -9.8%0.5%1.8 $0.83 9/15/2022214,400 shares $218,688.00 -1.1%0.6%1.9 $1.02CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. EVGN Short Interest - Frequently Asked Questions What is Evogene's current short interest? Short interest is the volume of Evogene shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 97,800 shares of EVGN short. Learn More on Evogene's current short interest. What is a good short interest ratio for Evogene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVGN shares currently have a short interest ratio of 1.0. Learn More on Evogene's short interest ratio. Is Evogene's short interest increasing or decreasing? Evogene saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 97,800 shares, an increase of 40.3% from the previous total of 69,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evogene's short interest compare to its competitors? Here is how the short interest of companies compare to Evogene: Lipocine Inc. (3.49%), DURECT Co. (3.24%), SeaStar Medical Holding Co. (3.85%), CareCloud, Inc. (0.98%), Spectral AI, Inc. (3.13%), NeuroOne Medical Technologies Co. (1.26%), Theratechnologies Inc. (0.10%), Inspira Technologies Oxy B.H.N. Ltd. (1.06%), Exagen Inc. (0.05%), Femasys Inc. (4.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Evogene stock? Short selling EVGN is an investing strategy that aims to generate trading profit from Evogene as its price is falling. EVGN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evogene? A short squeeze for Evogene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVGN, which in turn drives the price of the stock up even further. How often is Evogene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVGN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Lipocine Short Interest Data DURECT Short Interest Data SeaStar Medical Short Interest Data CareCloud Short Interest Data Spectral AI Short Interest Data NeuroOne Medical Technologies Short Interest Data Theratechnologies Short Interest Data Inspira Technologies Oxy B.H.N. Short Interest Data Exagen Short Interest Data Femasys Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVGN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company